These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 22656448)
1. The interactions of amphiphilic antisense oligonucleotides with serum proteins and their effects on in vitro silencing activity. Felber AE; Bayó-Puxan N; Deleavey GF; Castagner B; Damha MJ; Leroux JC Biomaterials; 2012 Sep; 33(25):5955-65. PubMed ID: 22656448 [TBL] [Abstract][Full Text] [Related]
2. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity. Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930 [TBL] [Abstract][Full Text] [Related]
3. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides: from design to therapeutic application. Chan JH; Lim S; Wong WS Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890 [TBL] [Abstract][Full Text] [Related]
9. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties. Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352 [TBL] [Abstract][Full Text] [Related]
10. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry. Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818 [TBL] [Abstract][Full Text] [Related]
11. Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells. Rubenstein M; Guinan P In Vivo; 2010; 24(4):489-93. PubMed ID: 20668314 [TBL] [Abstract][Full Text] [Related]
12. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain. Shiraishi T; Nielsen PE Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333 [TBL] [Abstract][Full Text] [Related]
13. Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression. Rubenstein M; Hollowell CM; Guinan P In Vivo; 2011; 25(5):725-32. PubMed ID: 21753125 [TBL] [Abstract][Full Text] [Related]
14. Self assembling properties of aminated poly(glycerol methacrylate)s. Gao H; Elsabahy M; Giger EV; Ma J; Prud'homme RE; Leroux JC J Control Release; 2011 Nov; 152 Suppl 1():e142-3. PubMed ID: 22195809 [No Abstract] [Full Text] [Related]
15. Inhibition of VEGF mRNA by 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) antisense oligonucleotides and their influence on off-target gene expressions. Morita K; Yamate K; Kurakata S; Abe K; Watanabe K; Koizumi M; Imanishi T Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):503-21. PubMed ID: 16838842 [TBL] [Abstract][Full Text] [Related]
17. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation. Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084 [TBL] [Abstract][Full Text] [Related]
18. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Taylor JK; Zhang QQ; Wyatt JR; Dean NM Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916 [TBL] [Abstract][Full Text] [Related]
19. Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature. Anderson EM; Miller P; Ilsley D; Marshall W; Khvorova A; Stein CA; Benimetskaya L Cancer Gene Ther; 2006 Apr; 13(4):406-14. PubMed ID: 16195754 [TBL] [Abstract][Full Text] [Related]
20. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Kim SH; Jeong JH; Lee SH; Kim SW; Park TG Bioconjug Chem; 2008 Nov; 19(11):2156-62. PubMed ID: 18850733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]